nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—Disturbance in attention—Varenicline—nicotine dependence	0.0347	0.0581	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Varenicline—nicotine dependence	0.0304	0.0509	CcSEcCtD
Enzalutamide—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0266	0.0661	CbGpPWpGaD
Enzalutamide—Injury—Varenicline—nicotine dependence	0.0237	0.0397	CcSEcCtD
Enzalutamide—Hot flush—Varenicline—nicotine dependence	0.0233	0.039	CcSEcCtD
Enzalutamide—Amnesia—Varenicline—nicotine dependence	0.0232	0.0389	CcSEcCtD
Enzalutamide—Menopausal symptoms—Varenicline—nicotine dependence	0.0231	0.0387	CcSEcCtD
Enzalutamide—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0225	0.0559	CbGpPWpGaD
Enzalutamide—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.0207	0.0515	CbGpPWpGaD
Enzalutamide—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0201	0.0499	CbGpPWpGaD
Enzalutamide—Dry skin—Varenicline—nicotine dependence	0.02	0.0335	CcSEcCtD
Enzalutamide—Nasopharyngitis—Varenicline—nicotine dependence	0.0195	0.0327	CcSEcCtD
Enzalutamide—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0185	0.0459	CbGpPWpGaD
Enzalutamide—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0183	0.0455	CbGpPWpGaD
Enzalutamide—Bronchitis—Varenicline—nicotine dependence	0.0181	0.0304	CcSEcCtD
Enzalutamide—Pollakiuria—Varenicline—nicotine dependence	0.0174	0.0292	CcSEcCtD
Enzalutamide—Infestation NOS—Varenicline—nicotine dependence	0.0168	0.0281	CcSEcCtD
Enzalutamide—Infestation—Varenicline—nicotine dependence	0.0168	0.0281	CcSEcCtD
Enzalutamide—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.0165	0.0409	CbGpPWpGaD
Enzalutamide—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0161	0.04	CbGpPWpGaD
Enzalutamide—Epistaxis—Varenicline—nicotine dependence	0.0159	0.0265	CcSEcCtD
Enzalutamide—Sinusitis—Varenicline—nicotine dependence	0.0158	0.0264	CcSEcCtD
Enzalutamide—Hypoaesthesia—Varenicline—nicotine dependence	0.015	0.0251	CcSEcCtD
Enzalutamide—Urinary tract disorder—Varenicline—nicotine dependence	0.0149	0.025	CcSEcCtD
Enzalutamide—Oedema peripheral—Varenicline—nicotine dependence	0.0149	0.0249	CcSEcCtD
Enzalutamide—Connective tissue disorder—Varenicline—nicotine dependence	0.0148	0.0248	CcSEcCtD
Enzalutamide—Urethral disorder—Varenicline—nicotine dependence	0.0148	0.0248	CcSEcCtD
Enzalutamide—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.0144	0.0358	CbGpPWpGaD
Enzalutamide—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.014	0.0347	CbGpPWpGaD
Enzalutamide—Angiopathy—Varenicline—nicotine dependence	0.0137	0.0229	CcSEcCtD
Enzalutamide—Mental disorder—Varenicline—nicotine dependence	0.0132	0.0221	CcSEcCtD
Enzalutamide—Back pain—Varenicline—nicotine dependence	0.0127	0.0213	CcSEcCtD
Enzalutamide—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.0125	0.0309	CbGpPWpGaD
Enzalutamide—Vertigo—Varenicline—nicotine dependence	0.0118	0.0198	CcSEcCtD
Enzalutamide—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.0115	0.0285	CbGpPWpGaD
Enzalutamide—Convulsion—Varenicline—nicotine dependence	0.0114	0.0191	CcSEcCtD
Enzalutamide—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.0114	0.0282	CbGpPWpGaD
Enzalutamide—Hypertension—Varenicline—nicotine dependence	0.0113	0.019	CcSEcCtD
Enzalutamide—Arthralgia—Varenicline—nicotine dependence	0.0112	0.0187	CcSEcCtD
Enzalutamide—Anxiety—Varenicline—nicotine dependence	0.0112	0.0187	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0111	0.0186	CcSEcCtD
Enzalutamide—Infection—Varenicline—nicotine dependence	0.0107	0.0178	CcSEcCtD
Enzalutamide—Nervous system disorder—Varenicline—nicotine dependence	0.0105	0.0176	CcSEcCtD
Enzalutamide—Thrombocytopenia—Varenicline—nicotine dependence	0.0105	0.0176	CcSEcCtD
Enzalutamide—Skin disorder—Varenicline—nicotine dependence	0.0104	0.0174	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00977	0.0164	CcSEcCtD
Enzalutamide—Insomnia—Varenicline—nicotine dependence	0.0097	0.0162	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00926	0.0155	CcSEcCtD
Enzalutamide—Fatigue—Varenicline—nicotine dependence	0.00925	0.0155	CcSEcCtD
Enzalutamide—Asthenia—Varenicline—nicotine dependence	0.0077	0.0129	CcSEcCtD
Enzalutamide—Pruritus—Varenicline—nicotine dependence	0.00759	0.0127	CcSEcCtD
Enzalutamide—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00749	0.0186	CbGpPWpGaD
Enzalutamide—Diarrhoea—Varenicline—nicotine dependence	0.00734	0.0123	CcSEcCtD
Enzalutamide—Dizziness—Varenicline—nicotine dependence	0.00709	0.0119	CcSEcCtD
Enzalutamide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00684	0.017	CbGpPWpGaD
Enzalutamide—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00675	0.0168	CbGpPWpGaD
Enzalutamide—Headache—Varenicline—nicotine dependence	0.00672	0.0112	CcSEcCtD
Enzalutamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00669	0.0166	CbGpPWpGaD
Enzalutamide—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0066	0.0164	CbGpPWpGaD
Enzalutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00579	0.0144	CbGpPWpGaD
Enzalutamide—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00572	0.0142	CbGpPWpGaD
Enzalutamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00555	0.0138	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00553	0.0137	CbGpPWpGaD
Enzalutamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00542	0.0135	CbGpPWpGaD
Enzalutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00517	0.0128	CbGpPWpGaD
Enzalutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0051	0.0127	CbGpPWpGaD
Enzalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00476	0.0118	CbGpPWpGaD
Enzalutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00472	0.0117	CbGpPWpGaD
Enzalutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0047	0.0117	CbGpPWpGaD
Enzalutamide—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00469	0.0117	CbGpPWpGaD
Enzalutamide—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00465	0.0116	CbGpPWpGaD
Enzalutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00419	0.0104	CbGpPWpGaD
Enzalutamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00386	0.00958	CbGpPWpGaD
Enzalutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00382	0.0095	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00369	0.00916	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00335	0.00832	CbGpPWpGaD
Enzalutamide—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00313	0.00777	CbGpPWpGaD
Enzalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00311	0.00773	CbGpPWpGaD
Enzalutamide—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00307	0.00763	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00306	0.00759	CbGpPWpGaD
Enzalutamide—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00295	0.00732	CbGpPWpGaD
Enzalutamide—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00291	0.00722	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00288	0.00716	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00284	0.00706	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00265	0.00658	CbGpPWpGaD
Enzalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00252	0.00626	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00249	0.0062	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00246	0.00611	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00236	0.00587	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00223	0.00553	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0022	0.00546	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00217	0.0054	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00215	0.00535	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00205	0.00509	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00203	0.00505	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00202	0.00502	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.002	0.00498	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—CCAR1—nicotine dependence	0.00182	0.00452	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00142	0.00353	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00134	0.00333	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00132	0.00328	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000906	0.00225	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000794	0.00197	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000504	0.00125	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000493	0.00122	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000427	0.00106	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP2A7—nicotine dependence	0.000424	0.00105	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000381	0.000946	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000372	0.000924	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.00035	0.00087	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000347	0.000863	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000229	0.000569	CbGpPWpGaD
